>>> Up
>>> Down
>>> Reiterations
>>> Initiations
Gapping down
In reaction to disappointing earnings/guidance: QGEN -11.8%, VRTX -4.6%, GCO -4%, EXAS -3%
Select China related names showing weakness with the Shanghai down over 5% last night: JD -2.2%, JMEI -1.7%, JKS -1.5%, CSIQ -0.9%, VIPS -0.9%, SFUN -0.9%, YY -0.7%, CTRP -0.6%
Other news: ACI -64% (files Chapter 11 bankruptcy, agrees on terms of debt restructure deal with Senior lenders), ASTI -12.9% (files 48 mln share common stock offering by a selling stockholder), NURO -5.6% (files ~16.505 mln share common stock offering issuable upon conversion of outstanding shares of Series C Preferred Stock & upon exercise of certain outstanding warrants by selling securityholders), BCLI -2.9% (enters into collaborative agreement with Hadassah Medical Center in Jerusalem), CYTK -1.9% (presents analyses demonstrating predictive value of slow vital capacity for clinical outcomes in ALS)
Analyst comments: UA -4.3% (downgraded to Underweight from Equal-Weight at Morgan Stanley), VFC -2.3% (downgraded to Underweight from Equal-Weight at Morgan Stanley), MJN -1.8% (downgraded to Neutral from Overweight at JP Morgan), WETF -1.4% (downgraded to Sell from Neutral at Goldman), JPM -0.5% (downgraded to Neutral from Buy at Goldman
)
In reaction to disappointing earnings/guidance: QGEN -11.8%, VRTX -4.6%, GCO -4%, EXAS -3%
Select China related names showing weakness with the Shanghai down over 5% last night: JD -2.2%, JMEI -1.7%, JKS -1.5%, CSIQ -0.9%, VIPS -0.9%, SFUN -0.9%, YY -0.7%, CTRP -0.6%
Other news: ACI -64% (files Chapter 11 bankruptcy, agrees on terms of debt restructure deal with Senior lenders), ASTI -12.9% (files 48 mln share common stock offering by a selling stockholder), NURO -5.6% (files ~16.505 mln share common stock offering issuable upon conversion of outstanding shares of Series C Preferred Stock & upon exercise of certain outstanding warrants by selling securityholders), BCLI -2.9% (enters into collaborative agreement with Hadassah Medical Center in Jerusalem), CYTK -1.9% (presents analyses demonstrating predictive value of slow vital capacity for clinical outcomes in ALS)
Analyst comments: UA -4.3% (downgraded to Underweight from Equal-Weight at Morgan Stanley), VFC -2.3% (downgraded to Underweight from Equal-Weight at Morgan Stanley), MJN -1.8% (downgraded to Neutral from Overweight at JP Morgan), WETF -1.4% (downgraded to Sell from Neutral at Goldman), JPM -0.5% (downgraded to Neutral from Buy at Goldman
)
Gapping up
In reaction to strong earnings/guidance/SSS: SQNM +6%, IRMD +5.8%, HCA +5.2%, KONA +4.9%, (prelim Q4 restaurant sales above consensus) ACOR +4.6%, (reports prelim Q4/2015 AMPYRA sales and 2016 guidance), SCVL +4.5%, EBS +3.3%, NVRO +3.1%, FOLD +2.5%, (Provides Full-Year 2016 Strategic Outlook and Financial Guidance) EVHC +0.8%, ARAY +0.7%
M&A news: AFFX +48.6% (to be acquired by Thermo Fisher (TMO) for $14.00/share in cash; expected to be immediately accretive to TMO's adjusted EPS), (exploring strategic alternatives; also released earnings), APOL +8.2% (exploring strategic alternatives; also released earnings), (to be acquired by Shire (SHPG) for ~$45.57/share), BXLT +6% (to be acquired by Shire (SHPG) for ~$45.57/share), (acquires AbVitro fro ~$78 mln), JUNO +4.6% (acquires AbVitro fro ~$78 mln), (receives IRS ruling for the planned spin-off of its biosciences business), EBS +3.3% (receives IRS ruling for the planned spin-off of its biosciences business), (to acquire BXLT for 45.57 per share), SHPG +2.9% (to acquire BXLT for 45.57 per share), (Starboard sends letter to the Board encouraging them to pursue more real estate deals, according to the WSJ), M +1.6% (Starboard sends letter to the Board encouraging them to pursue more real estate deals, according to the WSJ)
Select metals/mining stocks trading higher: MT +8.4%, HMY +6.2%, GFI +3.9%, KGC +3.7%, AU +2.4%, RIO +1.7%, VALE +1.5%, GOLD +1%
Other news: ATV +36.4% (announces share repurchase program of $2 mln), SCON +35.2% (reported its Conductus wire achieved a significant milestone for use in High Field Magnet applications), AVXL +21.1% (announces positive dose-response data for ANAVEX 2-73 in Alzheimer's disease patients), THLD +13.9% (Threshold Pharma and Merck KGaA (MKGAY) agree upon terms for the licensing back of all rights to evofosfamide to Threshold), SGYP +12.3% (announces positive phase 1b data with its second uroguanylin analog), VPCO +11.6% (withdrew previously announced offer to issue common stock and warrants in exchange for outstanding Units sold in the July 2015 offering), MNKD +6.1% (confirms Sanofi's (SNY) termination of the License and Collaboration Agreement), OCUL +5.6% (appoints Jonathan H. Talamo, M.D., as Chief Medical Officer), ZGNX +5.6% (Initiation of Phase 3 Program for ZX008 in Dravet Syndrome), ACRX +5.5% (provides anticipated 2016 milestones; reports initiation and completion of final Phase 3 trial in the U.S. for Zalviso, NDA Resubmission), ONTY +5.5% (announces the retirement of President and CEO Robert L. Kirkman, M.D. effective January 11), SGMO +4.6% (details its milestones and objectives for 2016), WLH +4.2% (commences $50 mln of 7.00% Senior Notes due 2022), RXDX +3.8% (details its strategic priorities for 2016), ILMN +3.5% (forms new company GRAIL for early detection blood-based screening; considered significant development in the war on cancer), SCMP +3.2% (granted a sole option to acquire an exclusive license to commercialize CPP-1X/sulindac combination product in North America from Cancer Prevention Pharma), IMGN +2.8% (provides anticipated milestones for 2016), CTIC +2.5% (reports positive progress of lead clinical programs; provides outlook for 2016), ARIA +2.4% (elects Alex Denner as Chairman), AA +2% (announces $1.5 bln long-term contract with GE Aviation (GE) for jet engine components; note AA reports earnings tonight), HMSY +1.4% (discloses it & the New York State Office of the Medicaid Inspector General entered into an amendment extending the term of existing third party liability contract), XONE +1.4% (enters into an At Market Issuance Sales Agreement with FBR and MLV & Co. to sell up to $50 mln in shares of its common stock), GPRO +1.4% (slight strength following Friday's weakness), NVS +1.3% (signs licensing agreement with Surface Oncology), MEG +1.3% (Nexstar Broadcasting (NXST) reiterates its commitment to acquire Media General, and to take all necessary actions to consummate a transaction )
Analyst comments: GM +1.9% (upgraded to Outperform from Neutral at Credit Suisse), AAPL +1.4% (upgraded to Buy from Neutral at Mizuho), WFC +1.1% (upgraded to Buy from Neutral at Goldman
)
In reaction to strong earnings/guidance/SSS: SQNM +6%, IRMD +5.8%, HCA +5.2%, KONA +4.9%, (prelim Q4 restaurant sales above consensus) ACOR +4.6%, (reports prelim Q4/2015 AMPYRA sales and 2016 guidance), SCVL +4.5%, EBS +3.3%, NVRO +3.1%, FOLD +2.5%, (Provides Full-Year 2016 Strategic Outlook and Financial Guidance) EVHC +0.8%, ARAY +0.7%
M&A news: AFFX +48.6% (to be acquired by Thermo Fisher (TMO) for $14.00/share in cash; expected to be immediately accretive to TMO's adjusted EPS), (exploring strategic alternatives; also released earnings), APOL +8.2% (exploring strategic alternatives; also released earnings), (to be acquired by Shire (SHPG) for ~$45.57/share), BXLT +6% (to be acquired by Shire (SHPG) for ~$45.57/share), (acquires AbVitro fro ~$78 mln), JUNO +4.6% (acquires AbVitro fro ~$78 mln), (receives IRS ruling for the planned spin-off of its biosciences business), EBS +3.3% (receives IRS ruling for the planned spin-off of its biosciences business), (to acquire BXLT for 45.57 per share), SHPG +2.9% (to acquire BXLT for 45.57 per share), (Starboard sends letter to the Board encouraging them to pursue more real estate deals, according to the WSJ), M +1.6% (Starboard sends letter to the Board encouraging them to pursue more real estate deals, according to the WSJ)
Select metals/mining stocks trading higher: MT +8.4%, HMY +6.2%, GFI +3.9%, KGC +3.7%, AU +2.4%, RIO +1.7%, VALE +1.5%, GOLD +1%
Other news: ATV +36.4% (announces share repurchase program of $2 mln), SCON +35.2% (reported its Conductus wire achieved a significant milestone for use in High Field Magnet applications), AVXL +21.1% (announces positive dose-response data for ANAVEX 2-73 in Alzheimer's disease patients), THLD +13.9% (Threshold Pharma and Merck KGaA (MKGAY) agree upon terms for the licensing back of all rights to evofosfamide to Threshold), SGYP +12.3% (announces positive phase 1b data with its second uroguanylin analog), VPCO +11.6% (withdrew previously announced offer to issue common stock and warrants in exchange for outstanding Units sold in the July 2015 offering), MNKD +6.1% (confirms Sanofi's (SNY) termination of the License and Collaboration Agreement), OCUL +5.6% (appoints Jonathan H. Talamo, M.D., as Chief Medical Officer), ZGNX +5.6% (Initiation of Phase 3 Program for ZX008 in Dravet Syndrome), ACRX +5.5% (provides anticipated 2016 milestones; reports initiation and completion of final Phase 3 trial in the U.S. for Zalviso, NDA Resubmission), ONTY +5.5% (announces the retirement of President and CEO Robert L. Kirkman, M.D. effective January 11), SGMO +4.6% (details its milestones and objectives for 2016), WLH +4.2% (commences $50 mln of 7.00% Senior Notes due 2022), RXDX +3.8% (details its strategic priorities for 2016), ILMN +3.5% (forms new company GRAIL for early detection blood-based screening; considered significant development in the war on cancer), SCMP +3.2% (granted a sole option to acquire an exclusive license to commercialize CPP-1X/sulindac combination product in North America from Cancer Prevention Pharma), IMGN +2.8% (provides anticipated milestones for 2016), CTIC +2.5% (reports positive progress of lead clinical programs; provides outlook for 2016), ARIA +2.4% (elects Alex Denner as Chairman), AA +2% (announces $1.5 bln long-term contract with GE Aviation (GE) for jet engine components; note AA reports earnings tonight), HMSY +1.4% (discloses it & the New York State Office of the Medicaid Inspector General entered into an amendment extending the term of existing third party liability contract), XONE +1.4% (enters into an At Market Issuance Sales Agreement with FBR and MLV & Co. to sell up to $50 mln in shares of its common stock), GPRO +1.4% (slight strength following Friday's weakness), NVS +1.3% (signs licensing agreement with Surface Oncology), MEG +1.3% (Nexstar Broadcasting (NXST) reiterates its commitment to acquire Media General, and to take all necessary actions to consummate a transaction )
Analyst comments: GM +1.9% (upgraded to Outperform from Neutral at Credit Suisse), AAPL +1.4% (upgraded to Buy from Neutral at Mizuho), WFC +1.1% (upgraded to Buy from Neutral at Goldman
)
PBoC's Ma: Stability of CNY against the basket needs to be improved, consensus is to refer more to currency basket
- CNY fixing to now take into account TWI basket stability
- CNY pressure will abate after the market gets used to the basket system
- There will be no tight peg to the currency basket
- Two-way CNY volatility against USD to increase, but PBoC to appropriately limit CNY volatility against USD
13:12:41 RTRS - NORWAY'S OIL MINISTER SAYS STATOIL'S BOARD AND MANAGEMENT MUST ASSESS OVERALL FINANCIAL SITUATION WHEN DECIDING HOW TO MEET COMPANY'S CHALLENGES STL.OL
An Australian-owned company has emerged as a frontrunner to take on a UK taxpayer-owned mortgage business, Sky News learns.
Sky News has learnt that UK Asset Resolution (UKAR) is in advanced talks about an arrangement which would see its mortgage servicing unit transferred to a private sector operator under a long-term contract.
Sources said on Monday that Capita, the outsourcing giant, was in competition with an Australian-owned company to take on the UKAR Corporate Services division.
A Treasury insider said that HML, a division of Computershare, was the frontrunner to secure a deal although they cautioned that it remained finely balanced.
A decision about the outcome and the terms of an agreement could come as soon as this month, they said.
The mortgage servicing platform, which administers the Government's Help to Buy scheme, is seen as an attractive asset because of its technology capability and the prospect for it to take on a broader range of business across the banking industry.
If successfully concluded, a deal would follow the £13bn sale of Granite, a securitisation vehicle established by Northern Rock in 2001.
It would also come as ministers prepare for a review of options for a £17bn Bradford & Bingley loan-book, which if sold would be the largest such sell-off in UK history.
Mr Osborne hailed the Granite sale in November as "another major milestone in clearing up the mess left by the financial crisis", saying it was the largest-ever sale of financial assets by a British government.
"We are now clear that taxpayers will get back more money from Northern Rock than they were forced to put in during the financial crisis.
"The highly competitive process, unprecedented scale, and the fact that these mortgages have been sold for almost £300m more than their book value demonstrates the confidence investors have in the UK, which has only been made possible by the success of our long term plan," the Chancellor said.
However, the Granite sale has attracted the scrutiny of MPs, in relation to both the identity of the buyer - Cerberus, a US investor - and the nature of the protection for customers.
B&B was bailed out by the Labour government in September 2008, with Santander UK buying its retail deposit business and the bank's remaining assets and liabilities - principally comprising its mortgage book, personal loan book, headquarters and relevant staff, and treasury assets and its wholesale liabilities - taken into public ownership.
UKAR declined to comment on the prospective Corporate Services deal.